The genome of Epstein-Barr virus type 2 strain AG876

Virology

Volumn 350, Issue 1, 2006, Pages 164-170

  Dolan, Aidan ^a   Addison, Clare ^a   Gatherer, Derek ^a   Davison, Andrew J ^a   McGeoch, Duncan J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Gammaherpesvirinae; Herpesviridae; Human herpesvirus 4; Lymphocryptovirus; Oncogenic virus; Viral evolution; Viral genomics; Viral latency

Indexed keywords

ALLELE; ARTICLE; B LYMPHOCYTE; CORRELATION ANALYSIS; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS 1; EPSTEIN BARR VIRUS TYPE 2; GENE LOCUS; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HERPES VIRUS; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOVIRINAE; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS GENOME; VIRUS LATENCY; VIRUS STRAIN; VIRUS TYPING;

ALLELES; BASE SEQUENCE; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENES, VIRAL; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; MOLECULAR SEQUENCE DATA;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 4 TYPE 2;

EID: 33744921669     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.01.015     Document Type: Article

References (50)

1. Arrand J.R., Rymo L., Walsh J.E., Björck E., Lindahl T., and Griffin B.E. Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Res. 9 (1981) 2999-3014
2. Arrand J.R., Young L.S., and Tugwood J.D. Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J. Virol. 63 (1989) 983-986
3. Baer R., Bankier A.T., Biggin M.D., Deininger P.I., Farrell P.J., Gibson T.G., Hatfull G., Hudson G.S., Satchwell S.C., Seguin C., Tuffnell P.S., and Barrell B.G. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310 (1984) 207-211
4. Bhatia K., Raj A., Gutiérrez M.I., Judde J.-G., Spangler G., Venkatesh H., and Magrath I.T. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13 (1996) 177-181
5. Burrows J.M., Khanna R., Sculley T.B., Alpers M.P., Moss D.J., and Burrows S.R. Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences. J. Virol. 70 (1996) 4829-4833
6. Busson P., Edwards R.H., Tursz T., and Raab-Traub N. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene. J. Gen. Virol. 76 (1995) 139-145
7. Cohen J.I., Wang F., Mannick J., and Kieff E. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 9558-9562
8. Cunningham C., and Davison A.J. A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197 (1993) 116-124
9. Dambaugh T.R., and Kieff E. Identification and nucleotide sequences of two similar tandem direct repeats in Epstein-Barr virus DNA. J. Virol. 44 (1982) 823-833
10. Dambaugh T., Hennessy K., Chamnankit L., and Kieff E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 7632-7636
11. de Jesus O., Smith P.R., Spender L.C., Karstegl C.E., Niller H.H., Huang D., and Farrell P.J. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J. Gen. Virol. 84 (2003) 1443-1450
12. Ewing B., and Green P. Base-calling of automated sequencer traces using Phred: II. Error probabilities. Genome Res. 8 (1998) 186-194
13. Ewing B., Hillier L., Wendl M.C., and Green P. Base-calling of automated sequencer traces using Phred: I. Accuracy assessment. Genome Res. 8 (1998) 175-185
14. Fruscalzo A., Marsili G., Busiello V., Bertolini L., and Frezza D. DNA sequence heterogeneity within the Epstein-Barr virus family of repeats in the latent origin of replication. Gene 265 (2001) 165-173
15. Habeshaw G., Yao Q.Y., Bell A.I., Morton D., and Rickinson A.B. Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J. Virol. 73 (1999) 965-975
16. Heller M., van Santen V., and Kieff E. Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections. J. Virol. 44 (1982) 311-320
17. Hitt M.M., Allday M.J., Hara T., Karran L., Jones M.D., Busson P., Tursz T., Ernberg I., and Griffin B.E. EBV gene expression in an NPC-related tumour. EMBO J. 8 (1989) 2639-2651
18. Honess R.W., Gompels U.A., Barrell B.G., Craxton M., Cameron K.R., Staden R., Chang Y.N., and Hayward G.S. Deviations from expected frequencies of CpG dinucleotides in herpesvirus DNAs may be diagnostic of differences in the states of their latent genomes. J. Gen. Virol. 70 (1989) 837-855
19. Inoue N., Kikuta H., and Yanagi K. Comparative sequence analysis of Epstein-Barr virus nuclear antigen-2 and -3B genes of a fresh Epstein-Barr virus-2 isolate. Intervirology 33 (1992) 180-186
20. Kieff E., and Rickinson A.B. Epstein-Barr virus and its replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology vol. 2 (2001), Lippincott Williams and Wilkins, Philadelphia 2511-2573
21. Lees J.F., Arrand J.E., Pepper S.DeV., Stewart J.P., Mackett M., and Arrand J.R. The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and B. Virology 195 (1993) 578-586
22. Leight E.R., and Sugden B. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev. Med. Virol. 10 (2000) 83-100
23. MacKenzie J., Gray D., Pinto-Pes R., Barrezueta L.F.M., Armstrong A.A., Alexander F.A., McGeoch D.J., and Jarrett R.F. Analysis of Epstein-Barr virus (EBV) nuclear antigen 1 subtypes in EBV-associated lymphomas from Brazil and the United Kingdom. J. Gen. Virol. 80 (1999) 2741-2745
24. McGeoch D.J. Molecular evolution of the γ-Herpesvirinae. Philos. Trans. R. Soc. London. B 356 (2001) 421-435
25. McGeoch D.J., and Davison A.J. The molecular evolutionary history of the herpesviruses. In: Domingo E., Webster R., and Holland J. (Eds). Origin and Evolution of Viruses (1999), Academic Press, London, SD 441-465
26. Midgley R.S., Blake N.W., Yao Q.Y., Croom-Carter D., Cheung S.T., Leung S.F., Chan A.T.C., Johnson P.J., Huang D., Rickinson A.B., and Lee S.P. Novel intertypic recombinants of Epstein-Barr virus in the Chinese population. J. Virol. 74 (2000) 1544-1548
27. Miller G., and Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. U.S.A. 70 (1973) 190-194
28. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
29. Parker B.D., Bankier A., Satchwell S., Barrell B., and Farrell P.J. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 179 (1990) 339-346
30. Pizzo P.A., Magrath I.T., Chattopadhyay S.K., Biggar R.J., and Gerber P. A new tumour-derived transforming strain of Epstein-Barr virus. Nature 272 (1978) 629-631
31. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., Tezcan I., Ersoy F., Kayserili H., Ugazio A.G., Brousse N., Muramatsu M., Notarangelo L.D., Kinoshita K., Honjo T., Fischer A., and Durandy A. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102 (2000) 565-575
32. Rickinson A.B., Young L.S., and Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J. Virol. 61 (1987) 1310-1317
33. Rivailler P., Jiang H., Young-gyu C., Quink C., and Wang F. Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model. J. Virol. 76 (2002) 421-426
34. Rivailler P., Young-gyu C., and Wang F. Complete genomic sequence of an Epstein-Barr virus related herpesvirus naturally infecting a New World primate: a defining point in the evolution of oncogenic lymphocryptoviruses. J. Virol. 76 (2002) 12055-12068
35. Rogozin I.B., and Kolchanov N.A. Somatic hypermutagenesis in immunoglobulin genes: II. Influence of neighbouring base sequences on mutagenesis. Biochim. Biophys. Acta 1171 (1992) 11-18
36. Rowe M., Young L.S., Cadwallader K., Petti L., Kieff E., and Rickinson A.B. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J. Virol. 63 (1989) 1031-1039
37. Sadler R.H., and Raab-Traub N. Structural analyses of the Epstein-Barr virus BamHI A transcripts. J. Virol. 69 (1995) 1132-1141
38. Sample J., Young L., Martin B., Chatman T., Kieff E., Rickinson A., and Kieff E. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64 (1990) 4084-4092
39. Sample J., Kieff E.F., and Kieff E.D. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes. J. Gen. Virol. 75 (1994) 2741-2746
40. Shim Y.-K., Kim C.-W., and Lee W.-K. Sequence variation of EBNA2 of Epstein-Barr virus isolates from Korea. Mol. Cells 8 (1998) 226-232
41. Smith P.R., Gao Y., Karran L., Jones M.D., Snudden D., and Griffin B.E. Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. J. Virol. 67 (1993) 3217-3225
42. Staden R., Beal K.F., and Bonfield J.K. The Staden package 1998. Methods Mol. Biol. 132 (2000) 115-130
43. Tao Q., and Robertson K.D. Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin. Immunol. 109 (2003) 53-63
44. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
45. Wrightham M.N., Stewart J.P., Janjua N.J., Pepper S.DeV., Sample C., Rooney C.M., and Arrand J.R. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208 (1995) 521-530
46. Yao Q.Y., Tierney R.J., Croom-Carter D., Cooper G.M., Ellis C.J., Rowe M., and Rickinson A.B. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals. J. Virol. 70 (1996) 4895-4903
47. Yates J., Warren N., Reisman D., and Sugden B. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 3806-3810
48. Yoshikawa K., Okazaki I., Eto T., Kinoshita K., Muramatsu M., Nagaoka H., and Honjo T. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296 (2002) 2033-2036
49. Zeng M.S., Li D.J., Liu Q.L., Song L.B., Li M.Z., Zhang R.H., Yu X.J., Wang H.M., Ernberg I., and Zeng Y.X. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J. Virol. 79 (2005) 15323-15330
50. Zimber U., Adldinger H.K., Lenoir G.M., Vuillaume M., Knebel-Doeberitz M.V., Laux G., Desgranges C., Wittmann P., Freese U.K., Schneider U., and Bornkamm G.W. Geographical prevalence of two types of Epstein-Barr virus. Virology 154 (1986) 56-66